Wthn
Wthn is a technology company.
Financial History
Wthn has raised $8.0M across 2 funding rounds.
Frequently Asked Questions
How much funding has Wthn raised?
Wthn has raised $8.0M in total across 2 funding rounds.
Wthn is a technology company.
Wthn has raised $8.0M across 2 funding rounds.
Wthn has raised $8.0M in total across 2 funding rounds.
WTHN is a modern wellness clinic chain specializing in acupuncture and Traditional Chinese Medicine (TCM), blending ancient practices with contemporary accessibility. It offers in-studio services like personalized acupuncture, cupping, acupressure, and herbal remedies at three New York City locations (Flatiron, Williamsburg, Upper West Side), alongside at-home products such as beauty tools, kits, and bundles for stress relief, pain management, better sleep, and facial rejuvenation.[1][4] Targeting urban professionals seeking science-backed, holistic solutions for everyday wellness amid faltering Western healthcare, WTHN raised $5M in Series A funding in 2023 led by L Catterton to fuel omnichannel expansion beyond NYC studios.[2] With under 31 employees and revenue below $5M, it emphasizes licensed acupuncturists (many with Master's or Doctorates in Acupuncture) trained in its proprietary program.[1][4]
WTHN emerged from co-founder Dr. Shari Auth's expertise as Chief Healing Officer, leveraging her background in TCM to modernize acupuncture for urban lifestyles. The idea crystallized as consumers increasingly turned to Eastern remedies for pain and stress, forsaken by traditional U.S. healthcare, leading to the launch of sleek NYC studios combining spa vibes with medical-grade treatments.[2][4] Early traction built around personalized "Prevent//Heal//Glow" protocols, attracting clients with affordable, elevated experiences from licensed practitioners. A pivotal moment came with the 2023 $5M Series A from L Catterton—backers of wellness brands like Thorne HealthTech—enabling product expansion and growth from two initial studios.[2]
While not a pure technology company, WTHN rides the wellness tech-adjacent wave of digital-physical hybrids in healthtech, digitizing TCM through e-commerce platforms, app data tracking, and personalized recommendations amid a $5T+ global wellness boom. Timing aligns with post-pandemic demand for Eastern alternatives like Ayurveda and functional mushrooms, as brands like Apothékary ($25M projected 2023 sales) and MUD\WTR blend ancient rites with modern retail.[2] Market forces favor it: rising consumer skepticism of Western medicine, L Catterton-backed scaling (e.g., Thorne acquisition), and NYC's dense urban demographic needing quick relief. WTHN influences the ecosystem by normalizing acupuncture via approachable branding, paving the way for tech integrations like AI-driven TCM personalization in emerging health apps.[2][4]
WTHN is poised for national expansion, leveraging its $5M funding to open more studios and scale e-commerce amid surging TCM adoption. Trends like AI-enhanced personalization, tele-wellness, and East-West hybrid supplements will shape its path, potentially integrating app-based treatment tracking or VR-guided self-acupuncture. Its influence may evolve from NYC niche player to category leader, especially if it captures the "anything to feel better" consumer wave—echoing its origins in making ancient healing a modern essential.[2][4]
Wthn has raised $8.0M in total across 2 funding rounds.
Wthn's investors include Alpaca VC, Bam Ventures, Dream VC, Rainfall Ventures, Acre Venture Partners, Batalion Capital, Brand Foundry Ventures, L'ATTITUDE Ventures, Torch Capital, Blake Mycoskie, Carmelo Anthony (Melo7 Tech Partners), Gary Hirshberg.
Wthn has raised $8.0M across 2 funding rounds. Most recently, it raised $5.0M Series A in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2024 | $5.0M Series A | Alpaca VC, Bam Ventures, Dream VC, Rainfall Ventures | |
| Apr 1, 2018 | $3.0M Seed | Acre Venture Partners, Bam Ventures, Batalion Capital, Brand Foundry Ventures, L'ATTITUDE Ventures, Rainfall Ventures, Torch Capital, Blake Mycoskie, Carmelo Anthony (Melo7 Tech Partners), Gary Hirshberg |